Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Hims CEO Slams Novo Nordisk For 'Anticompetitive Demands' After Ozempic Maker Abruptly Ends Partnership: 'We Refuse To Be Strong-Armed'

Hims Hers Health Inc. (NYSE:HIMS), CEO Andrew Dudum, has accused Novo Nordisk of exerting anticompetitive pressure to prioritize its weight-loss drug Wegovy over patient needs after the abrupt termination of its partnership with a pharmaceutical giant.

Benzinga

Ocugen (OCGN) Shares Slide Following Merger Agreement: What's Going On?

Shares of Ocugen Inc (NASDAQ:OCGN) are trading lower by more than 8% Monday afternoon. The company earlier announced a definitive agreement to merge its subsidiary OrthoCellix with Carisma Therapeutics in an all-stock deal.

Benzinga

CorMedix Stock Hits New 52-Week High On Updated Guidance: The Details

CorMedix Inc (NASDAQ:CRMD) shares are hitting new 52-week highs on Monday after the company raised its sales guidance for the second quarter.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Purdue Pharma's $7B opioid settlement plan could get votes from victims and cities

A judge could decide Friday whether to advance OxyContin maker Purdue Pharma's $7 billion-plus plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

A judge could advance Purdue Pharma's $7B opioid settlement after all 50 states back it

A judge is being asked to clear the way for local governments and individual victims to vote on OxyContin maker Purdue Pharma’s plan to settle thousands of lawsuits over the toll of opioids

The Independent UK

FDA to offer faster drug reviews to companies promoting 'national priorities'

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health

The Independent UK

Purdue Pharma to pay $7.4 billion in opioid lawsuit settlement

Besides the hefty financial reward, the settlement also ends the Sackler family’s ownership of Purdue Pharma and their ability to sell opioids in the U.S.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Second patient death reported with gene therapy for muscular dystrophy

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene therapy for muscular dystrophy

The Independent UK

Purdue Pharma $7.4bn opioid settlement wins broad support from US states

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

Al Jazeera

PPE from company linked to Mone did not meet required safety standards, court told

Department of Health wants refund of £122m spent on unused surgical gowns, but PPE Medpro says it went into contract with ‘eyes wide open’

The Guardian - UK

Suspected drug deaths in Scotland up by a third in three months, figures show

SUSPECTED drug deaths in Scotland have risen by a third in the first three months of this year, figures have revealed ...

The National (Scotland)

Top RFK Jr. aide attacks US health system while running company that promotes wellness alternatives

A top aide to Health Secretary Robert F

The Independent UK

Rachel Reeves to announce £86bn for science and technology in spending review

Regions will be handed up to £500 million with local leaders given powers to decide how investment is targeted in their communities.

Evening Standard

Can Birth Control Give You Brain Tumors? These 400 Women Say The Pfizer Shot Did

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and insufficient safety warnings.

International Business Times UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - US

23andMe back on the auction block after former CEO makes 11th-hour bid

Anne Wojcicki, ex-CEO of the DNA testing firm, put in a $305m bid, upending Regeneron’s $256m agreement

Bored Panda

26 Examples Of Packaging So Misleading, It’s Basically A Scam, As Shared On This Online Community

These packages look like they were intentionally designed to lure away our money.

International Business Times

At No Cost to Federal Government a Lifeline for America's Communities

At its heart, 340B is about getting medicine—and the healthcare services needed to ensure their safe and effective use—to people who otherwise might go without it.

Evening Standard

Drug maker Indivior joins the flight from London share listings

Pharmaceuticals company said most of its product sales and shareholders are US based

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

New ‘superbug’ antibiotic to treat sepsis and pneumonia enters last phase of testing

It is hoped that the drug zosurabalpin will be approved by the end of the decade

Evening Standard

Harris urges US against tariff hikes on pharma and microchip sectors

The Irish deputy premier has written to US Secretary for Commerce Howard Lutnick on two sectors that are key to Ireland’s economy.

The Independent UK

NHS rolls out ‘Amazon-style’ app for prescriptions to free up pharmacies

High street pharmacies including Boots have already adopted the technology

The Independent UK

Company decides not to rebuild chlorine plant with history of fires, explosions and toxic clouds

The company that operated a Georgia chlorine plant with a history of explosions and chemical fires that created toxic clouds has decided not to rebuild its Conyers manufacturing plant

The Guardian - US

Bankrupt DNA testing firm 23andMe to be purchased for $256m

Drugmaker Regeneron Pharmaceuticals’ capture of genetic testing firm in bankruptcy auction raises privacy concerns

The Independent UK

Biotechnology company Regeneron buying 23andMe for $256 million

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection

International Business Times

High Times For German Cannabis Firm Amid Medical Boom

At an undisclosed site in Germany's Bavaria state, pharmaceutical CEO Philip Schetter opens a 75-centimetre (30-inch) thick steel door that secures his wares: vast amounts of cannabis.

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Scottish Government

Food and Drug Administration

344 stories

PPE Medpro

245 stories

the London Stock Exchange

190 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.